Detailansicht

Wissensnetz

Person

Alexandra Jensen (1976-)

Ärztin

Name	Alexandra Jensen
Zeit	1976- (Lebensdaten)
Ort	Heidelberg (Geburtsort) Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	PD Dr. med. (Medizinische Fakultät der Univ. Heidelberg)
Beruf	Ärztin (charakteristischer Beruf)
Variante	Alexandra Désirée Jensen A. D. Jensen Alexandra D. Jensen
Beziehung	Philipps-Universität Marburg (seit 06/2018) Universität Heidelberg. Medizinische Fakultät (10/2013-07/2017) Deutsches Krebsforschungszentrum (01/2010-04/2015)
Weitere Angaben	Fachärtzin am DKFZ, Abteilung Radiologische Onkologie
Datensatztyp	Person
GND-Nummer	136129552
Datensatz-ID	136129552
Beteiligt an alle anzeigen Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation? Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN) Simultaneous integrated boost for adjuvant treatment of breast cancer- intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab Untersuchung von DNA-Doppelstrangbrüchen und Zellzyklus unter dFdC (Gemcitabine) an humanen WIDR-Colan Carzinom Zellen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Alexandra Jensen (1976-)

Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck

Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma

Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome

Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Simultaneous integrated boost for adjuvant treatment of breast cancer- intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT

Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab

Untersuchung von DNA-Doppelstrangbrüchen und Zellzyklus unter dFdC (Gemcitabine) an humanen WIDR-Colan Carzinom Zellen